Share  Print  [-] [+]

China Everbright Limited Announces Final Closing of CEL Global Investment Fund, L.P.

Monday, January 7, 2019


(Press Release) - China Everbright Limited (“Everbright”, stock code: 165.HK) is proud to announce that “CEL Global Investment Fund, L.P.”, a fund managed by Everbright (“the Fund”), has concluded its final closing on 21st December, 2018 with a US$539-million-dollar fund commitments from a diverse group of investors, including corporate investors, family offices, and fund of funds.

As of final closing, the Fund has invested over US$350 million into various portfolios, with focus on high value-added sectors such as industrial communications and advanced manufacturing. The Fund has been established in the second quarter of 2016, which primarily invests in equities of the companies located in North America, Europe, and Asia with a proven operational track record and a sound business model, with strong growth in China.

The Fund’s current investment portfolios include the acquisitions of Burke Porter Group Ltd, the world leading supplier and solution provider of intelligent machinery equipment, Lapmaster Group Holdings, LLC (“Precision Surfacing Solutions”) from the US, an industry leader in the design and manufacture of micron accuracy precision abrasive finishing machinery, and invested in the Hong Kong-based Cloud Light Technology Limited, a market leader for providing customized solutions for optical transceivers and active optical cables for use in datacentres.

The operations of the Fund’s portfolio companies have achieved tremendous growth and organic expansions since the Fund’s investment, with significant development in their global operations.  The management and professionals of the portfolio companies have also benefited from having a strong shareholder’s support for their bolt-on acquisitions globally and the timely expansion plans in China.

The Fund will continue to look for opportunities in North America, Europe, and Asia with minority or majority with control investments.

 

View full announcement here